A court ruling in the European Union (EU) giving Brussels the jurisdiction to investigate life sciences firm Illumina’s $8 billion takeover bid of biotech company Grail could set a precedent granting regulators wider oversight of deals regardless of the revenue and other particulars. The General...
July 13, 2022
A court ruling in the European Union (EU) giving Brussels the jurisdiction to investigate life sciences firm Illumina’s $8 billion takeover bid of biotech company Grail could set a precedent granting regulators wider oversight of deals regardless of the revenue and other particulars. The General Court of the European Union upheld a decision by the […]
